Biotech stocks are having a big day Friday, helping to almost erase the sector's under-performance in the fourth quarter.
Take a look at where we stand:
Why the big rebound? Biogen Idec (BIIB - Get Report) and Gilead Sciences (GILD - Get Report) are certainly helping. Both received positive news from European regulators Friday, which seems to have triggered another round of buying.
GILD data by YCharts
Europe was also very good to Ariad Pharmaceuticals (ARIA - Get Report) today. The stock is Friday's top performer:
ARIA data by YCharts
-- Reported by Adam Feuerstein in Boston. Follow Adam Feuerstein on Twitter.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts